Related Experiment Video
Updated: Jun 1, 2025
12:26
Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
18.5K
CDK5: Insights into its roles in diseases
Jiahui Wang1, Chong Zhang2,3, Tingting Jiang1
1Institute of Pathogenic Biology, Guilin Medical University, Guilin, 541199, China.
Molecular Biology Reports
|January 21, 2025
Summary
Cyclin-dependent kinase 5 (CDK5) plays key roles in neurological and metabolic diseases. Inhibiting CDK5 offers potential for new disease treatments and diagnostic approaches.
Area of Science:
- Biochemistry
- Molecular Biology
- Pathology
Background:
- Cyclin-dependent kinase 5 (CDK5) is a serine/threonine protein kinase.
- CDK5 is widely expressed in the central nervous system and implicated in neurological diseases.
- CDK5 also contributes to metabolic disorders, psychiatric conditions, and cancer progression.
Purpose of the Study:
- To review the structure and biological functions of CDK5.
- To highlight CDK5's regulatory roles in disease development via substrate phosphorylation.
- To examine the therapeutic potential of CDK5 inhibition.
Main Methods:
- Literature review of CDK5's structure and function.
- Analysis of CDK5's role in various pathological processes.
- Exploration of CDK5 as a therapeutic target.
Main Results:
- CDK5 regulates critical physiological and pathological processes.
- CDK5's phosphorylation of substrates drives disease development.
- CDK5 inhibition shows therapeutic promise.
Conclusions:
- CDK5 is a significant factor in neurological and other diseases.
- Targeting CDK5 offers novel diagnostic and therapeutic strategies.
- Further research into CDK5 inhibition is warranted.
Keywords:
Cyclin-dependent kinase 5(CDK5)Neurodegenerative diseasesPhosphorylationProtein kinaseTumorMore Related Videos
Related Concept Videos
02:15M-Cdk Drives Transition Into Mitosis
5.5K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.5K
02:34Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
02:39Positive Regulator Molecules
5.3K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.3K
02:38Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
02:23Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K